2018 American Transplant Congress » Poster Session C: Transplant Infectious Diseases

Date: Monday, June 4, 2018

Time: 6:00pm-7:00pm

Location: Hall 4EF

Session Type: Poster Session

Meeting: 2018 American Transplant Congress

6:00pm-7:00pm: Clostridium difficile Recurrence in Abdominal Organ Transplant Recipients: Metronidazole versus Oral Vancomycin

A. Moorman,¹ S. Todd,¹ G. Lyon III,² H. Triemer.¹

6:00pm-7:00pm: In Vitro Evaluation of Antibiotic Persistence in Pseudomonas aeruginosa and Staphylococcus aureus Isolates from Cystic Fibrosis Patients

J. Fose, D. Bruckbauer, M. Jorgenson, W. Rose.

6:00pm-7:00pm: A National Survey of Valganciclovir Dosing Strategies in Pediatric Solid Organ Transplant Recipients

S. Shaikh, N. Panek, J. Park.

6:00pm-7:00pm: A Retrospective Review of De Novo Coccidioidomycosis among Remote Solid Organ Transplant Recipients in Arizona

T. Zangeneh,¹ J. August,¹ N. Beatty,¹ K. Asbury,² L. Mi,² J. Blair.²

6:00pm-7:00pm: Bacterial Complications in Liver Transplant Recipients Undergoing Biliary Tract Manipulation: Effect of an Antibiotic Prophylaxis Protocol

C. Clifford, N. Theodoropoulos, J. Daly, L. Gibson, S. Mehta, H. Malik, A. Bozorgzadeh.

6:00pm-7:00pm: Bloodstream Infection Caused by Enteric Organisms during the First 6 Months after Intestinal Transplant

J. Simkins,¹ J. Morillas-Rodriguez,¹ M. Morris,¹ L. Abbo,¹ J. Camargo,¹ R. Vianna.²

6:00pm-7:00pm: CMV-Specific CD8+ T-Cell Immune Competence Score as Predictor of Outcome for CMV Infection after Transplantation

A. Meesing,¹ R. Abraham,² R. Razonable.¹

6:00pm-7:00pm: Characterization of Mycobacterium Tuberculosis Memory T Cell Subsets in Solid Organ Transplant Recipients with Previously Treated Active Tuberculosis

S. Nellimarla, Y. Natori, V. Ferreira, S. Husain, A. Humar, D. Kumar.

6:00pm-7:00pm: Clostridium Difficile Infection after Liver Transplant is Associated with Poor Long-Term Survival

A. Ahearn, P. Mahboub, N. Theodoropoulos, B. Movahedi, P. Martins, M. Campion, R. Nathan, A. Bozorgzadeh.

6:00pm-7:00pm: Colistin (COL) in Solid Organ Transplant Recipients (SOTR): Friend or Foe?

K. Neyra, C. Huauya Leuyacc, C. Kovacs, V. Athans, E. Cober.

6:00pm-7:00pm: Cytomegalovirus Infection in Pediatric Solid Organ Transplant Recipients and Role of Prophylaxis

G. Nance,¹ A. Serluco,¹ S. Deshpande,^2,1 R. Garro,^3,1 R. George,^3,1 M. Kelleman,³ R. Liverman.¹

6:00pm-7:00pm: Daptomycin Minimum Inhibitory Concentration (MIC) of Vancomycin Resistant Enterococcal (VRE) Blood Isolates Correlates with Allograft Failure in Orthotopic Liver Transplant (OLT) Recipients

R. Lee,¹ G. Haidar,² J. Lewis,³ S. Arif,⁴ J. Hand,⁵ E. Holaday,⁶ H. Clauss,⁶ J. Goldman,⁷ A. Nellore.¹

6:00pm-7:00pm: Diagnosis and Prevalence of Strongyloidiasis in Solid Organ Transplant Patients

H. Pritchard,¹ V. Hemmige,¹ R. Mejia,² A. Restrepo.¹

6:00pm-7:00pm: Donor Bacteremia Does Not Impact Survival Following Heart Transplantation: A UNOS Registry Review

S. Hirji, A. Woolley, M. Pelletier, P. Shekar, F. Yazdchi, H. Mallidi, S. Singh.

6:00pm-7:00pm: Donor-Derived Hepatitis B Virus (HBV) Infection: Analysis of the OPTN/UNOS Ad Hoc Disease Transmission Advisory Committee (DTAC)

N. Theodoropoulos, S. Tlusty, G. Vece, G. Berry, J. Bucio, L. Danziger-Isakov, D. Florescu, D. Goldberg, C. Ho, R. La Hoz, K. Lilly, M. Malinis, A. Mehta, M. Nalesnik, R. Sawyer, L. Strasfeld, R. Wood, M. Michaels, C. Wolfe.

6:00pm-7:00pm: Efficacy of Two Valganciclovir Dosing Strategies in Intermediate and High-Risk Liver Transplant Recipients

K. Belfield,¹ M. Malinis,² E. Cohen.¹

6:00pm-7:00pm: Evaluation of Hepatitis B Vaccination in Transplant Candidates

M. Bosaeed, Y. AlJishi, S. Husain, C. Rotstein, A. Humar, D. Kumar.

6:00pm-7:00pm: Evaluation of Risk Factors for Progression of Low Level CMV Viremia in Solid Organ Transplant Recipients

Y. Natori, A. Humar, A. Alghamdi, D. Kumar.

6:00pm-7:00pm: Evaluation of Risk Factors for Vancomycin Resistant Enterococcus (VRE) Infection in Adult Liver Transplant Recipients

E. Aldag, R. Pedersen, V. Gunabushanam, A. Sahajpal, L. Fehrenbacher, D. Kramer.

6:00pm-7:00pm: Evaluation of a Change in CMV Prevention Strategy Following Pediatric SOT

S. Pangonis, A. Miethke, F. Flores, M. Schecter, S. Kocoshis, D. Lazear, T. Hemmelgam, B. Taylor, G. Paulsen, L. Danziger-Isakov.

6:00pm-7:00pm: HIV-Positive Donors to HIV-Positive Transplant Recipients: The Italian Experience

P. Grossi,¹ D. Dalla Gasperina,¹ A. Petrolo,¹ D. Lombardi,¹ M. Balsamo,¹ M. Moioli,² G. Travi,² M. Merli,² F. Ferla,² M. Tozzi,¹ L. De Carlis,² G. Carcano,¹ M. Puoti,² A. Nanni Costa.³

6:00pm-7:00pm: HOPE Act Deceased Organ Donors: True and False Positive Donors

C. Durand,¹ S. Seaman,¹ M. Bowring,¹ B. Doby,¹ D. Ostrander,¹ A. Redd,¹ M. Waldram,¹ S. Huprikar,² B. Haydel,² S. Lerner,² S. Florman,² N. Turgeon,³ R. Friedman-Moraco,³ A. Massie,¹ D. Segev.¹

6:00pm-7:00pm: Host Factors and Clinical Spectrum of Adenovirus Infection in Pediatric Solid Organ Transplantation: A Closer Look at the Infant, the Toddler and the Child

C. Del Valle Mojica, S. Chen, H. Gans.

6:00pm-7:00pm: Identifying Differences in Antimicrobial Resistance with a Liver Transplant Antibiogram

J. Rago, M. Crotty, E. Milas, E. Dominguez.

6:00pm-7:00pm: Impact of Fluconazole Prophylaxis on Fungal Infections in Liver Transplant Recipients

K. Roach,¹ S. Todd,² M. Lyon,² R. Subramanian.²

6:00pm-7:00pm: Impact of High Dose Acyclovir Cytomegalovirus Prophylaxis Failure in Abdominal Solid Organ Transplant Recipients

J. Fose, M. Jorgenson, M. Siodlak, G. Leverson, J. Smith, R. Redfield.

6:00pm-7:00pm: Impact of Influenza Vaccine Implementation by Transplant Pharmacy in Solid Organ Transplant Recipients

S. Gattis,¹ I. Yildirim,^1,2 S. Serluco,¹ C. McCracken,² R. Liverman.¹

6:00pm-7:00pm: Impact of Positive Donor Blood Cultures in Liver Transplant Recipients

D. Bley, D. Lo, G. Lyon III, R. Subramanian, S. Todd.

6:00pm-7:00pm: Infection Outcomes in Solid Organ Transplant Recipients Receiving Trimethoprim-Sulfamethoxazole as Opposed to Atovaquone for Prophylaxis

A. Drelick,¹ W. Mowrey,² G. Minamoto.³

6:00pm-7:00pm: Isavuconazole – The Real-World Use Experience

H. Hassouna, V. Athans, K. Brizendine.

6:00pm-7:00pm: Micafungin Prophylaxis in Liver Transplant Recipients at High Risk for Invasive Fungal Infections

A. Nolan, N. Harriott, K. Startsman.

6:00pm-7:00pm: Mitigating Risk: Post-Exposure Prophylaxis in Liver Transplant Recipients from Donors with Potential Infectious Exposure

A. Nolan, D. Yarosh, S. Shaikh.

6:00pm-7:00pm: National Landscape of HIV+ Liver Transplant Candidates

A. Shaffer,¹ A. Thomas,¹ A. Massie,¹ S. Gustafson,² J. Snyder,² B. Shelton,³ R. Reed,³ J. Locke,³ D. Segev,¹ C. Durand.¹

6:00pm-7:00pm: Nontuberculous Mycobacteria in Lung Transplant Recipients: Prevalence, Risk Factors and Impact on Survival and Graft Function

D. Friedman, C. Cervera, K. Halloran, G. Tyrrell, K. Doucette.

6:00pm-7:00pm: Prevalence and Infection-Related Outcomes Associated with Transplant Tourism

J. Slomovic, S. Humar, D. Kumar, A. Humar.

6:00pm-7:00pm: Risk Factors and Outcomes with Carbapenem-Resistant Enterobacteriaceae Bloodstream Infections among Solid Organ Transplant Recipients

J. Anesi,¹ E. Blumberg,¹ E. Lautenbach,¹ J. Omorogbe,¹ P. Tolomeo,¹ P. Tamma,² K. Thom,³ K. Alby,¹ W. Bilker,¹ A. Werzen,³ K. Nemati,² J. Han.¹

6:00pm-7:00pm: Safety and Tolerability of Therapy for Latent Tuberculosis Infection: A 16-Year Review

Y. AlJishi, M. Bosaeed, S. Husain, C. Rotstein, A. Humar, D. Kumar.

6:00pm-7:00pm: Screening Coccidioides Serology in Kidney Transplant Recipients: A 10-Year Cross-Sectional Analysis

K. Phonphok,¹ T. Duong,¹ N. Datta,¹ O. Beaird,² J. Shaenman,² S. Bunnapradist.¹

6:00pm-7:00pm: Solid Organ Transplantation and Data Mining: Risk Factors for Invasive Fungal Disease in Heart Transplant Recipients

N. Barros, D. Xie, C. Yek, T. Liu, X. Li, B. Adams-Huet, J. Martinez, S. Garg, J. Grodin, R. Morelend, A. Amin, F. Aras, J. Thibodeau, P. Mammen, M. Peltz, M. Drazner, W. Ring, R. Haley, R. La Hoz.

6:00pm-7:00pm: Strongyloides Pre-Transplant Screening in Solid Organ Transplantation (SOT): Single Center Analysis

M. Al-Obaidi,¹ K. Vigil,¹ R. Hasbun,¹ A. De Golovine,² V. Machicao,³ L. Ostrosky,¹ S. Bynon,⁴ M. Nigo.¹

6:00pm-7:00pm: T2Candida for Diagnosis of Candidemia in Solid Organ Transplant Recipients

T. McCarty, J. Baddley, J. Locke, R. Mannon, D. Eckhoff, V. Rusanov, S. Moser, P. Pappas.

6:00pm-7:00pm: Tacrolimus and Isavuconazole Therapy: What about the Drug Interaction?

C. Gill,¹ N. Mercuro,¹ R. Kenney,¹ A. Jantz,¹ B. Summers,¹ N. Sulejmani,¹ S. Davis.^1,2

6:00pm-7:00pm: The Clinical Efficacy of Seasonal Influenza Vaccination – Characteristics of Two Outbreaks of Influenza A(H1N1) in Immunocompromised Patients

I. Helanterä,¹ R. Janes,² V-.J. Anttila.³

6:00pm-7:00pm: Therapeutic Drug Monitoring (TDM) of Suspension (SUS), Extended-Release (ER), and Intravenous (IV) Posaconazole (POS) at a Large Transplant Center

G. Haidar, R. Shields, C. Clancy, M. Nguyen.

6:00pm-7:00pm: Timing of Infections after Total Artificial Heart Implantation. What Did We Learn?

H. Chambers, A. Kalil, D. Florescu.

6:00pm-7:00pm: Transmission of Rabies through Solid Organ Transplant: A Big Issue in China

J. Zhang, J. Lin, Y. Tian, L. Ma, W. Sun, L. Zhang, Y. Zhu, W. Qiu, L. Zhang.

6:00pm-7:00pm: Treatment of Multi-Drug Resistant Gram Negative Infections after Solid Organ Transplant

M. Heldman, B. Nelson, T. Babu, M. Ison.

6:00pm-7:00pm: You've Gotta Have HOPE: Seeking HIV Donors in a Large US OPO

A. Friedman,¹ S. Huprikar,² K. Delli Carpini.¹

« View all sessions from the 2018 American Transplant Congress